The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease (Q38003501)
Jump to navigation
Jump to search
scientific article published on 17 April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease |
scientific article published on 17 April 2012 |
Statements
1 reference
The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease (English)
1 reference
Apostolos Kontzias
1 reference
Petros Efthimiou
1 reference
17 April 2012
1 reference
1 reference
Identifiers
1 reference